Telehealth

A new FAIR Health report finds 57.5% of commercially insured Americans have a chronic condition, with costs nearly doubling for patients with just one.

As CFO Scott Ullem preps for a key presentation, Edwards balances record innovation and strong financials against new regulatory hurdles. What's at stake?

After its stock plummeted post-IPO, Chinese health-tech firm POMDOCTOR faces a Nasdaq delisting threat, forcing a reckoning with its massive losses.

Following the departure of its R&D head, Immunocore streamlines leadership, betting on internal experts to drive its next wave of innovative therapies.

The market for drugs like Ozempic and Wegovy is set to explode, fueled by new oral pills, expanded uses for heart and liver disease, and fierce competition.

A breakthrough in orthodontics, Smartee’s new technology offers a non-surgical solution for severe jaw issues, challenging traditional methods.

Calian Group prepares to unveil its Q1 FY2026 results, with investors keenly watching for signs of sustained growth and strategic progress in key sectors.

A landmark study validates Panakeia's AI, which provides critical cancer biomarker results in minutes, promising to revolutionize patient care globally.

A new partnership links instant at-home health screenings to Amazon's One Medical, promising ultimate convenience but raising questions about the future of care.

A new partnership will leverage advanced technology to transform care for thousands of Medicare patients, aiming for better outcomes and lower costs.

New studies prove seeing the same doctor cuts ER visits and costs, but patients also crave instant access. Can modern healthcare deliver both?

With promising brain scan data, a deep therapeutic pipeline, and a cash runway into 2027, Radiopharm Theranostics is gaining significant momentum.

Curitics Health Solutions' new AI platform targets administrative bloat, promising to free clinicians from paperwork and speed up patient care approvals.

A new 'Agentic Voice Platform' promises to automate routine tasks, reduce costs, and free up clinicians, but can it build patient trust?

A renewed call for nonprofits to tackle U.S. health disparities, offering funding, mentorship, and a chance to scale proven community-based innovations.

Wisp's first acquisition marks a major strategy shift from D2C to enterprise care, aiming to close critical gaps in women's sexual health and PrEP access.

A new study confirms AI can detect major heart conditions from one brief ultrasound clip, empowering any clinician to perform life-saving cardiac screening.

Neurocrine Biosciences begins a Phase 2 trial for a new tardive dyskinesia drug, aiming to build on its market dominance and offer new hope for patients.

Aja Health inks a deal with Greatway Financial to sell its MyCare Ally program and upgrades its GOeVisit platform for advanced virtual care services.

A new strategic partnership aims to dismantle commercialization hurdles, promising faster access to life-saving therapies for rare disease patients.